CVS Health Corporation’s Stock Price Plummets to $73.88, Experiencing a 4.04% Overnight Drop

CVS Health Corporation (CVS)

73.88 USD -3.11 (-4.04%) Volume: 14.35M

CVS Health Corporation’s stock price experienced a significant drop overnight, closing at 73.88 USD, a decrease of 4.04% in this trading session. Despite a high trading volume of 14.35M, the company’s stock has seen a year-to-date decrease of 6.43%, indicating a challenging market for investors.

Latest developments on CVS Health Corporation

Today, CVS Health Corp’s stock price is seeing movement following a series of key events. Despite losses in the market, the company’s stock has outperformed competitors, according to reports from Yahoo Finance and MarketWatch. Additionally, CVS Health has announced an increase in its dividend, signaling potential growth for the company. A new report from CVS Health highlights opportunities for the future of community pharmacy, while healthcare stocks overall have taken a hit after Humana’s forecast. The closure of CVS stores and pharmacies has also been a topic of discussion, with MarketBeat and wcrz.com reporting on the potential impact on the company’s financial health. In other news, CVS has named a new CMO, as reported by MediaPost Communications.

CVS Health Corporation on Smartkarma

According to experts on Smartkarma, an independent investment research network, CVS Health Corporation has been receiving positive analyst coverage. Both Baptista Research and their team of analysts have published research on the company, highlighting its strong performance and growth potential.

In their reports, Baptista Research notes that CVS Health Corporation has exceeded Wall Street’s expectations in terms of revenue and earnings. The company’s integrated model has proven to be successful, with significant progress made in restoring its Medicare Advantage Star rating. The Pharmacy & Consumer Wellness segment has also achieved impressive revenues, with the retail pharmacy business showing strong performance.

Additionally, Baptista Research points out that CVS Health Corporation has made strategic acquisitions, such as Signify Health and Oak Street Health, which have strengthened its position in value-based care. Efforts to integrate these assets with CVS Health’s existing offerings are expected to drive further growth. As a result, the analysts give CVS Health Corporation a ‘Buy’ rating with a revised target price.

A look at CVS Health Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Cvs Health Corp, a well-known pharmacy health care provider, is expected to have a positive long-term outlook according to Smartkarma’s Smart Scores. With a score of 4 for both value and dividend, the company is projected to have a strong financial standing and provide steady returns to its shareholders. Additionally, Cvs Health Corp received a score of 3 for both growth and resilience, indicating potential for future expansion and a strong ability to withstand economic challenges. Its momentum score of 4 suggests that the company is performing well and gaining momentum in the market. Overall, Cvs Health Corp‘s Smart Scores point towards a promising future for the company.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma